Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Peter Norman. (2001) Therapeutic approaches to respiratory diseases excluding asthma:Trends from the patent literature 1997 - 2000. Expert Opinion on Therapeutic Patents 11:2, pages 307-322.
Read now
Read now
Giuseppe AM Giardina, Mario Grugni & Luca F Raveglia. (2000) Recent advances in neurokinin-3 receptor antagonists. Expert Opinion on Therapeutic Patents 10:6, pages 939-960.
Read now
Read now
RW Clarke. (2000) Synaptic mechanisms in nociception: emerging targets for centrally-acting analgesics. Emerging Therapeutic Targets 4:2, pages 173-189.
Read now
Read now
Articles from other publishers (13)
Margit Pissarek. (2014) Neuropeptide Receptors in Pain Circuitries: Useful Targets for CNS Imaging with Non-Peptide Ligands Suitable for PET?. World Journal of Neuroscience 04:04, pages 353-383.
Crossref
Crossref
Lee A. Dawson, Paul W. Smith & Jeannette M. Watson. 2012. Targets and Emerging Therapies for Schizophrenia. Targets and Emerging Therapies for Schizophrenia
381
424
.
Ken-Ichi Noritake, Junko Suzuki, Toshiki Matsuoka, Toshihiko Makino, Hitoshi Ohnishi, Kazuhiro Shimomura, Yoshihisa Uenoyama, Hiroko Tsukamura, Kei-Ichiro Maeda & Atsushi Sanbuissho. (2011) Testicular toxicity induced by a triple neurokinin receptor antagonist in male dogs. Reproductive Toxicology 31:4, pages 440-446.
Crossref
Crossref
Hamid R. Hoveyda, Marie-Odile Roy, Sebastien Blanc, Sophie Noël, Joseph M. Salvino, Mark A. Ator & Graeme Fraser. (2011) Discovery of 3-aryl-5-acylpiperazinyl-pyrazoles as antagonists to the NK3 receptor. Bioorganic & Medicinal Chemistry Letters 21:7, pages 1991-1996.
Crossref
Crossref
Hiroshi Tsuchida, Sakiko Takahashi, Emi Nosaka, Osamu Mukaiyama, Makoto Yamashita & Kiyoshi Morimoto. (2008) Novel triple neurokinin receptor antagonist CS-003 strongly inhibits neurokinin related responses. European Journal of Pharmacology 586:1-3, pages 306-312.
Crossref
Crossref
Osamu Mukaiyama, Kiyoshi Morimoto, Emi Nosaka, Sakiko Takahashi & Makoto Yamashita. (2004) Involvement of enhanced neurokinin NK3 receptor expression in the severe asthma guinea pig model. European Journal of Pharmacology 498:1-3, pages 287-294.
Crossref
Crossref
Manal N. S. Saudi, Sherif A. F. Rostom, Hesham T. Y. Fahmy & Ibrahim M. El Ashmawy. (2003) Synthesis of 2‐(4‐Biphenylyl)quinoline‐4‐carboxylate and Carboxamide Analogs. New Human Neurokinin‐3 (hNK‐3) Receptor Antagonists. Archiv der Pharmazie 336:3, pages 165-174.
Crossref
Crossref
Rafaela L. Ribeiro & Thereza C.M. De Lima. (2002) Participation of GABAA receptors in the modulation of experimental anxiety by tachykinin agonists and antagonists in mice. Progress in Neuro-Psychopharmacology and Biological Psychiatry 26:5, pages 861-869.
Crossref
Crossref
Xavier Langlois, Cindy Wintmolders, Paula te Riele, Josée E. Leysen & Mirek Jurzak. (2001) Detailed distribution of Neurokinin 3 receptors in the rat, guinea pig and gerbil brain: a comparative autoradiographic study. Neuropharmacology 40:2, pages 242-253.
Crossref
Crossref
L Raveglia. (1999) Investigation of SAR requirements of SR 142801 through an indexed combinatorial library in solution. European Journal of Medicinal Chemistry 34:10, pages 825-835.
Crossref
Crossref
G.A.M Giardina, M Artico, S Cavagnera, A Cerri, E Consolandi, S Gagliardi, D Graziani, M Grugni, D.W.P Hay, M.A Luttmann, R Mena, L.F Raveglia, R Rigolio, H.M Sarau, D.B Schmidt, G Zanoni & C Farina. (1999) Replacement of the quinoline system in 2-phenyl-4-quinolinecarboxamide NK-3 receptor antagonists. Il Farmaco 54:6, pages 364-374.
Crossref
Crossref
R E Jordan, D Smart, P Grimson, N Suman-Chauhan & A T McKnight. (1998)
Activation of the cloned human NK
3
receptor in Chinese Hamster Ovary cells characterized by the cellular acidification response using the Cytosensor microphysiometer
. British Journal of Pharmacology 125:4, pages 761-766.
Crossref
Crossref
Sander G. Mills. 1997.
51
60
.